Koyfin Home > Directory > Health Care > Aldeyra Therapeu > Issuance of Common Stock

Aldeyra Therapeu Issuance of Common Stock Chart (ALDX)

Aldeyra Therapeu annual/quarterly Issuance of Common Stock from 2013 to 2020.
  • Aldeyra Therapeu Issuance of Common Stock for the quarter ending June 06, 2020 was $12m a 99.07% increase of 12m year over year
  • Aldeyra Therapeu Issuance of Common Stock for the last 12 months ending June 06, 2020 was $24m a -184.16% decrease of -44m year over year
  • Aldeyra Therapeu Annual Issuance of Common Stock for 2019 was $9m a -785.75% decrease of -73m from 2018
  • Aldeyra Therapeu Annual Issuance of Common Stock for 2018 was $82m a 54.11% increase of 44m from 2017
  • Aldeyra Therapeu Annual Issuance of Common Stock for 2017 was $38m a 66.12% increase of 25m from 2016
Other Cash Flow Metrics:
  • Aldeyra Therapeu Cash Flow from Operations for the quarter ending September 09, 2018 was $-8m a 34.73% decrease of -3m year over year
  • Aldeyra Therapeu Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $2m a 206.88% increase of 5m year over year
View Chart On Koyfin

Quarterly ALDX Issuance of Common Stock Data

06/2020$12m
03/2020$3m
12/2019$8m
09/2019$0m
03/2019$1m
12/2018$68m
09/2018$1m
06/2018$9m
03/2018$4m
12/2017$0m

Annual ALDX Issuance of Common Stock Data

2019$9m
2018$82m
2017$38m
2016$13m
2015$29m
2014$10m
2013$0m